Stock listing
BOATS:KPRX Kiora Pharmaceuticals, Inc. Stock
US listing (BOATS) of Kiora Pharmaceuticals, Inc. · home listing NASDAQ:KPRX
Follow Kiora Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:KPRX
$1.56 USD -0.20 (-11.4%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:KPRX
- Day range
- $1.55 – $1.83 USDOct 30, 2026
- Volume
- 100,700 sharesOct 30, 2026
- Market cap
- $6.90M USDAt the close on Oct 30, 2026 · price × 4.42M shares outstanding
- 52-week range
- $1.55 – $2.91 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $53,221 USDMedian day 14,300 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:KPRX · Home | $1.56 USD | -0.20 (-11.4%) | 100,700 | $1.78 | $1.825 | $1.55 | $1.76 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:KPRX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.56 | -0.20 | -11.4% | $1.78 | $1.825 | $1.55 | 100,700 | |
| $1.76 | -0.60 | -25.4% | $2.21 | $2.22 | $1.73 | 488,700 | |
| $2.36 | +0.06 | +2.6% | $2.32 | $2.57 | $2.32 | 29,900 | |
| $2.30 | +0.09 | +4.1% | $2.20 | $2.31 | $2.20 | 16,500 | |
| $2.21 | -0.08 | -3.5% | $2.28 | $2.28 | $2.21 | 25,000 | |
| $2.29 | -0.03 | -1.3% | $2.32 | $2.37 | $2.24 | 24,400 | |
| $2.32 | -0.02 | -0.9% | $2.36 | $2.36 | $2.32 | 900 | |
| $2.34 | +0.01 | +0.4% | $2.35 | $2.37 | $2.32 | 30,100 | |
| $2.33 | -0.05 | -2.1% | $2.38 | $2.41 | $2.32 | 23,500 | |
| $2.38 | -0.02 | -0.8% | $2.37 | $2.38 | $2.36 | 3,400 | |
| $2.40 | -0.01 | -0.4% | $2.42 | $2.42 | $2.36 | 11,900 | |
| $2.41 | -0.06 | -2.4% | $2.46 | $2.46 | $2.35 | 25,400 | |
| $2.47 | 0.00 | 0.0% | $2.47 | $2.49 | $2.45 | 18,300 | |
| $2.47 | -0.09 | -3.5% | $2.55 | $2.55 | $2.47 | 3,000 | |
| $2.56 | +0.02 | +0.8% | $2.53 | $2.56 | $2.52 | 12,800 | |
| $2.54 | +0.01 | +0.4% | $2.515 | $2.57 | $2.515 | 4,500 | |
| $2.53 | 0.00 | 0.0% | $2.52 | $2.54 | $2.48 | 24,300 | |
| $2.53 | +0.03 | +1.2% | $2.51 | $2.54 | $2.49 | 21,000 | |
| $2.50 | -0.03 | -1.2% | $2.52 | $2.62 | $2.50 | 20,200 | |
| $2.53 | -0.03 | -1.2% | $2.56 | $2.57 | $2.52 | 8,600 | |
| $2.56 | -0.02 | -0.8% | $2.55 | $2.56 | $2.55 | 3,400 | |
| $2.58 | +0.02 | +0.8% | $2.57 | $2.58 | $2.56 | 16,800 | |
| $2.56 | -0.04 | -1.5% | $2.57 | $2.57 | $2.56 | 2,400 | |
| $2.60 | -0.07 | -2.6% | $2.63 | $2.64 | $2.58 | 6,700 | |
| $2.67 | +0.04 | +1.5% | $2.619 | $2.67 | $2.619 | 6,700 | |
| $2.63 | -0.04 | -1.5% | $2.623 | $2.63 | $2.60 | 2,400 | |
| $2.67 | +0.05 | +1.9% | $2.63 | $2.67 | $2.58 | 19,400 | |
| $2.62 | -0.09 | -3.3% | $2.73 | $2.75 | $2.62 | 10,100 | |
| $2.71 | +0.03 | +1.1% | $2.70 | $2.80 | $2.63 | 7,600 | |
| $2.68 | -0.08 | -2.9% | $2.75 | $2.75 | $2.62 | 6,200 | |
| $2.76 | +0.09 | +3.4% | $2.63 | $2.85 | $2.63 | 49,300 | |
| $2.67 | +0.07 | +2.7% | $2.65 | $2.70 | $2.63 | 20,000 | |
| $2.60 | 0.00 | 0.0% | $2.60 | $2.63 | $2.57 | 28,500 | |
| $2.60 | -0.05 | -1.9% | $2.66 | $2.66 | $2.59 | 19,600 | |
| $2.65 | 0.00 | 0.0% | $2.70 | $2.70 | $2.601 | 19,000 | |
| $2.65 | +0.07 | +2.7% | $2.59 | $2.65 | $2.59 | 10,500 | |
| $2.58 | +0.09 | +3.6% | $2.48 | $2.58 | $2.47 | 15,900 | |
| $2.49 | -0.02 | -0.8% | $2.51 | $2.60 | $2.49 | 15,800 | |
| $2.51 | -0.04 | -1.6% | $2.64 | $2.64 | $2.49 | 9,500 | |
| $2.55 | 0.00 | 0.0% | $2.58 | $2.625 | $2.54 | 4,500 | |
| $2.55 | -0.04 | -1.5% | $2.63 | $2.66 | $2.55 | 3,000 | |
| $2.59 | +0.08 | +3.2% | $2.53 | $2.64 | $2.53 | 10,300 | |
| $2.51 | 0.00 | 0.0% | $2.54 | $2.56 | $2.50 | 14,500 | |
| $2.51 | -0.11 | -4.2% | $2.52 | $2.555 | $2.50 | 14,100 | |
| $2.62 | -0.04 | -1.5% | $2.67 | $2.67 | $2.62 | 2,500 | |
| $2.66 | +0.07 | +2.7% | $2.58 | $2.72 | $2.58 | 8,700 | |
| $2.59 | 0.00 | 0.0% | $2.58 | $2.592 | $2.53 | 20,400 | |
| $2.59 | -0.16 | -5.8% | $2.74 | $2.75 | $2.59 | 25,244 | |
| $2.75 | +0.09 | +3.4% | $2.65 | $2.75 | $2.65 | 11,049 | |
| $2.66 | +0.04 | +1.5% | $2.61 | $2.66 | $2.532 | 15,800 | |
| $2.62 | +0.02 | +0.8% | $2.54 | $2.63 | $2.54 | 9,600 | |
| $2.60 | +0.01 | +0.4% | $2.57 | $2.68 | $2.52 | 34,300 | |
| $2.59 | 0.00 | 0.0% | $2.56 | $2.62 | $2.496 | 14,600 | |
| $2.59 | +0.04 | +1.6% | $2.56 | $2.62 | $2.49 | 10,800 | |
| $2.55 | -0.04 | -1.5% | $2.53 | $2.585 | $2.48 | 41,200 | |
| $2.59 | -0.05 | -1.9% | $2.64 | $2.65 | $2.56 | 12,700 | |
| $2.64 | +0.02 | +0.8% | $2.60 | $2.65 | $2.58 | 20,400 | |
| $2.62 | +0.04 | +1.6% | $2.57 | $2.64 | $2.56 | 12,468 | |
| $2.58 | -0.06 | -2.3% | $2.65 | $2.65 | $2.58 | 12,221 | |
| $2.64 | +0.08 | +3.1% | $2.60 | $2.64 | $2.575 | 23,500 | |
| $2.56 | +0.02 | +0.8% | $2.53 | $2.565 | $2.52 | 13,400 | |
| $2.54 | +0.07 | +2.8% | $2.51 | $2.54 | $2.48 | 17,200 | |
| $2.47 | -0.12 | -4.6% | $2.57 | $2.60 | $2.42 | 40,500 | |
| $2.59 | +0.03 | +1.2% | $2.54 | $2.605 | $2.52 | 6,500 | |
| $2.56 | +0.005 | +0.2% | $2.575 | $2.61 | $2.522 | 4,600 | |
| $2.555 | -0.015 | -0.6% | $2.54 | $2.56 | $2.46 | 4,700 |
- Ticker
- BOATS:KPRX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Kiora Pharmaceuticals In-Licenses Late-Stage, Oral Neuroprotective Calpain Inhibitor for Central Retinal Artery Occlusion (CRAO) with Planned Expansion into NAION; Asset Completed Phase 3 Clinical Trial in CRAO in Japan
Latest deck · Oct 29, 2026
Investor Presentation (October 2026)
Investor deck · 29 slides
Latest news
Kiora Pharmaceuticals In-Licenses Late-Stage, Oral Neuroprotective Calpain Inhibitor for Central Retinal Artery Occlusion (CRAO) with Planned Expansion into NAION; Asset Completed Phase 3 Clinical Trial in CRAO in Japan
Oct 29, 2026
Closed $1.76 (-25.4%) on Oct 29, 2026
Kiora Pharmaceuticals Appoints Keith J. Lane as Executive Vice President of Global Clinical Development and Regulatory Affairs
Sep 8, 2026
Closed $2.51 (-1.6%) on Sep 8, 2026
Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation
Aug 19, 2026
Closed $2.60 (+0.4%) on Aug 19, 2026
Kiora Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 7, 2026
Closed $2.64 (+3.1%) on Aug 7, 2026
Kiora Pharmaceuticals to Participate in Piper Sandler Virtual Ophthalmology Symposium
Jul 2, 2026
Closed $2.63 (-1.1%) on Jul 2, 2026
Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model
Jun 18, 2026
Closed $2.53 (-1.6%) on Jun 18, 2026
Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 8, 2026
Closed $2.45 (0.0%) on May 8, 2026
Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway
Apr 14, 2026
Closed $2.44 (0.0%) on Apr 14, 2026
Kiora Pharmaceuticals Announces Private Placement for Up to $24 Million Led by Perceptive Advisors
Apr 7, 2026
Closed $2.16 (+6.9%) on Apr 7, 2026
Kiora Pharmaceuticals Announces Management Team Changes
Apr 2, 2026
Closed $1.94 (-0.5%) on Apr 2, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 29 slides · Oct 29, 2026
Investor Presentation (October 2026)
Investor deck · 29 slides · Oct 29, 2026
Investor Presentation (2026)
Investor deck · 24 slides · 2026
H.C. Wainwright 5th Annual Ophthalmology Virtual Conference (August 2025)
Conference · 25 slides · Aug 13, 2025
Kiora Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 81 in all · newest Oct 29, 2026 · oldest 2021
- Decks
- 40 decks · latest Oct 29, 2026
Where Kiora Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:KPRX · Home listing | NASDAQ | United States | USD |
| BOATS:KPRX · This page | BOATS | United States | USD |
| Lang & Schwarz:A40EG5 | Lang & Schwarz | Germany | EUR |
| Munich:7EY | Munich | Germany | EUR |
| Frankfurt:7EY | Frankfurt | Germany | EUR |
| gettex:7EY | gettex | Germany | EUR |
Log in to ask 6ix AI your own questions about Kiora Pharmaceuticals, Inc.